Moving PD-1 Blockade With Pembrolizumab Into Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 15 Nov 2017 Status changed from suspended to recruiting.
- 21 Sep 2017 Status changed from recruiting to suspended.
- 19 Apr 2016 Status changed from not yet recruiting to recruiting.